Sodium Tetradecyl Sulfate

Basic Information

Item Value
DrugBank ID DB00464
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 100

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 esophageal varices without bleeding KG + DL
2 esophageal varices with bleeding KG + DL
3 Steel syndrome KG + DL
4 pseudo-von Willebrand disease KG + DL
5 Immunoerythromyeloid hypoplasia KG + DL
6 primary release disorder of platelets KG + DL
7 reticular dysgenesis KG + DL
8 autosomal dominant familial periodic fever KG + DL
9 hypophosphatasia KG + DL
10 lung fibrosis-immunodeficiency-46,XX gonadal dysgenesis syndrome KG + DL
11 syndrome with combined immunodeficiency KG + DL
12 T-B+ severe combined immunodeficiency due to gamma chain deficiency KG + DL
13 hepatic infarction KG + DL
14 non-severe combined immunodeficiency KG + DL
15 severe combined immunodeficiency due to LCK deficiency KG + DL
16 adenosine deaminase deficiency KG + DL
17 T-B+ severe combined immunodeficiency due to CD45 deficiency KG + DL
18 combined immunodeficiency due to CRAC channel dysfunction KG + DL
19 combined immunodeficiency, X-linked KG + DL
20 hepatic veno-occlusive disease KG + DL
21 absent thumb-short stature-immunodeficiency syndrome KG + DL
22 pancytopenia due to IKZF1 mutations KG + DL
23 vitamin A deficiency (disease) KG + DL
24 facial dysmorphism-immunodeficiency-livedo-short stature syndrome KG + DL
25 hepatic veno-occlusive disease-immunodeficiency syndrome KG + DL
26 Glanzmann thrombasthenia KG + DL
27 peliosis hepatis KG + DL
28 familial apolipoprotein C-II deficiency KG + DL
29 immuno-osseous dysplasia KG + DL
30 autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis KG + DL
31 Omenn syndrome KG + DL
32 monosomy X KG + DL
33 periodic fever-infantile enterocolitis-autoinflammatory syndrome KG + DL
34 primary immunodeficiency due to a defect in adaptive immunity KG + DL
35 hemolytic uremic syndrome, atypical, susceptibility to, 1 KG + DL
36 Charcot-Marie-Tooth disease KG + DL
37 late-onset retinal degeneration KG + DL
38 severe combined immunodeficiency (disease) KG + DL
39 pigmented paravenous retinochoroidal atrophy KG + DL
40 macular degeneration, X-linked atrophic KG + DL
41 immunodeficiency with factor H anomaly KG + DL
42 oligocone trichromacy KG + DL
43 purine nucleoside phosphorylase deficiency KG + DL
44 retinoschisis of fovea KG + DL
45 progressive bifocal chorioretinal atrophy KG + DL
46 X-linked retinal dysplasia KG + DL
47 cone dystrophy KG + DL
48 T-cell immunodeficiency, congenital alopecia, and nail dystrophy KG + DL
49 Aland island eye disease KG + DL
50 helicoid peripapillary chorioretinal degeneration KG + DL

(Showing top 50 of 100 predictions)

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). 本報告僅供研究參考,不構成醫療建議。

This site uses Just the Docs, a documentation theme for Jekyll.